Intermittent Fasting Safe, Effective for Reducing Visceral Adipose Tissue
By Lori Solomon HealthDay Reporter
WEDNESDAY, Jan. 22, 2025 -- Time-restricted eating (TRE) may not add additional benefit in visceral adipose tissue reduction over the Mediterranean diet for people with overweight or obesity, according to a study published online Jan. 7 in Nature Medicine.
Manuel Dote-Montero, Ph.D., from the Sport and Health University Research Institute in Granada, Spain, and colleagues randomly assigned 197 participants with overweight or obesity to usual care (education about the Mediterranean diet; 49 participants), early TRE (49 participants), late TRE (52 participants), or self-selected TRE (47 participants) for 12 weeks.
The researchers found no significant differences in visceral adipose tissue changes for early TRE (mean difference [MD], −4 percent), late TRE (MD, −6 percent), or self-selected TRE (MD, −3 percent) versus usual care. There were similar findings when TRE groups were combined. No serious adverse events were noted, and five participants reported mild adverse events. Across TRE groups, adherence was high (85 to 88 percent).
"These findings suggest that adding TRE, irrespective of eating window timing, offers no additional benefit over a Mediterranean diet alone in reducing visceral adipose tissue," the authors write.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
School-Based Asthma Therapy Boosts Asthma Control, Cuts Acute Health Care Use
THURSDAY, April 24, 2025 -- School-based asthma therapy (SBAT) can help improve children’s asthma control and decrease acute health care utilization, according to a study...
Brensocatib Leads to Lower Rate of Pulmonary Exacerbations in Bronchiectasis
THURSDAY, April 24, 2025 -- For patients with bronchiectasis, brensocatib leads to a lower annualized rate of pulmonary exacerbations, according to a study published in the April...
Cold Hypersensitivity, Heavy Leg Sensation Tied to Risk for Varicose Veins
THURSDAY, April 24, 2025 -- Cold hypersensitivity and a feeling of heaviness in the legs are linked to the presence of varicose veins in adults aged 30 years and older, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.